Differences in the redox status of human visceral and subcutaneous adipose tissues - relationships to obesity and metabolic risk

被引:49
|
作者
Jankovic, Aleksandra [1 ]
Korac, Aleksandra [2 ]
Srdic-Galic, Biljana [3 ]
Buzadzic, Biljana [1 ]
Otasevic, Vesna [1 ]
Stancic, Ana [1 ]
Vucetic, Milica [1 ]
Markelic, Milica [2 ]
Velickovic, Ksenija [2 ]
Golic, Igor [2 ]
Korac, Bato [1 ]
机构
[1] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Physiol, Belgrade 11060, Serbia
[2] Univ Belgrade, Fac Biol, Ctr Electron Microscopy, Belgrade 11000, Serbia
[3] Univ Novi Sad, Fac Med, Dept Anat, Novi Sad 21000, Serbia
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2014年 / 63卷 / 05期
关键词
Redox regulation; Metabolism; Metabolic syndrome; INCREASED OXIDATIVE STRESS; LOW-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; REGIONAL DIFFERENCES; IN-VIVO; GLUCOSE-UPTAKE; NORMAL-WEIGHT; GLUTATHIONE; EXPRESSION; DYSFUNCTION;
D O I
10.1016/j.metabol.2014.01.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Metabolic homeostasis depends on adipocyte metabolic responses/processes, most of which are redox-regulated. Besides, visceral and subcutaneous adipose tissues (VAT and SAT, respectively) differ metabolically and in their contribution to metabolic complications, but their redox characteristics in humans are still unknown. To understand the molecular mechanisms of metabolic syndrome development, we analysed the redox characteristics of VAT and SAT in groups with various body weights and metabolic risks. Material and Methods. Fifty premenopausal women were classified according to body mass index into normal-weight and obese groups, and these groups were further sub-classified into metabolically healthy and metabolically obese ("at risk") based on the homeostasis model assessment of insulin resistance (HOMA-IR) index and the triglyceride, total-, LDL- and HDL-cholesterol levels. Antioxidant components, NADPH oxidase protein and 4-hydroxynonenal (4-HNE) levels were analysed in VAT and SAT. Results. Compared with the SAT, the VAT showed a higher basal level of glutathione (GSH) and GSH-dependent enzyme activities. Compared with the metabolically healthy normal-weight controls, the obese groups of women showed lower GSH levels in both depots. However, in these groups, additional prooxidative changes (increased NADPH oxidase and 4-HNE and decreased levels of SOD and/or CAT) were observed only in VAT. Conclusions. Because of the critical role of thiol-redox homeostasis in lipogenesis, interdepot-differences in the GSH-dependent antioxidant part may be connected to the higher metabolic activity found in VAT. Analogously, the lower GSH levels that occur during obesity and the corresponding additional redox imbalance may be signs of VAT metabolic dysfunction that underlie the subsequent metabolic impairment. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:661 / 671
页数:11
相关论文
共 50 条
  • [1] Physiological and metabolic differences between visceral and subcutaneous adipose tissues in Nile tilapia (Oreochromis niloticus)
    Wang, Ya-Wen
    Zhang, Ji-Lei
    Jiao, Jian-Gang
    Du, Xiao-Xia
    Limbu, Samwel Mchele
    Qiao, Fang
    Zhang, Mei-Ling
    Li, Dong-Liang
    Du, Zhen-Yu
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2017, 313 (05) : R608 - R619
  • [2] Exploring Visceral and Subcutaneous Adipose Tissue Secretomes in Human Obesity: Implications for Metabolic Disease
    Kahn, Darcy
    Macias, Emily
    Zarini, Simona
    Garfield, Amanda
    Berry, Karin Zemski
    MacLean, Paul
    Gerszten, Robert E.
    Libby, Andrew
    Solt, Claudia
    Schoen, Jonathan
    Bergman, Bryan C.
    ENDOCRINOLOGY, 2022, 163 (11)
  • [3] Differences in AMPK expression between subcutaneous and visceral adipose tissue in morbid obesity
    Martinez-Agustin, O.
    Hernandez-Morante, J. J.
    Martinez-Plata, E.
    Sanchez de Medina, F.
    Garaulet, M.
    REGULATORY PEPTIDES, 2010, 163 (1-3) : 31 - 36
  • [4] Mitochondrial respiration in subcutaneous and visceral adipose tissue from patients with morbid obesity
    Kraunsoe, Regitze
    Boushel, Robert
    Hansen, Christina Neigaard
    Schjerling, Peter
    Qvortrup, Klaus
    Stockel, Mikael
    Mikines, Kari J.
    Dela, Flemming
    JOURNAL OF PHYSIOLOGY-LONDON, 2010, 588 (12): : 2023 - 2032
  • [5] Screening of exosomal miRNAs derived from subcutaneous and visceral adipose tissues: Determination of targets for the treatment of obesity and associated metabolic disorders
    Yang, Zheng
    Wei, Zhuying
    Wu, Xia
    Yang, Huidi
    MOLECULAR MEDICINE REPORTS, 2018, 18 (03) : 3314 - 3324
  • [6] Expression of Clock Genes in Human Subcutaneous and Visceral Adipose Tissues
    Zanquetta, Melissa Moreira
    Correa-Giannella, Maria Lucia
    Giannella-Neto, Daniel
    Alonso, Paulino Alberto
    Martins Vaz Guimaraes, Ligia Maria
    Meyer, Alberto
    Ferreira Villares, Sandra Mara
    CHRONOBIOLOGY INTERNATIONAL, 2012, 29 (03) : 252 - 260
  • [7] A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity
    Insenser, Maria
    Montes-Nieto, Rafael
    Vilarrasa, Nuria
    Lecube, Albert
    Simo, Rafael
    Vendrell, Joan
    Escobar-Morreale, Hector F.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 363 (1-2) : 10 - 19
  • [8] Subcutaneous and visceral adipose tissue: structural and functional differences
    Ibrahim, M. Mohsen
    OBESITY REVIEWS, 2010, 11 (01) : 11 - 18
  • [9] Intrinsic Features in MicroRNA Transcriptomes Link Porcine Visceral Rather than Subcutaneous Adipose Tissues to Metabolic Risk
    Ma, Jideng
    Jiang, Zhi
    He, Shen
    Liu, Yingkai
    Chen, Lei
    Long, Keren
    Jin, Long
    Jiang, An'an
    Zhu, Li
    Wang, Jinyong
    Li, Mingzhou
    Li, Xuewei
    PLOS ONE, 2013, 8 (11):
  • [10] Metabolic Health Status Contributes to Transcriptome Alternation in Human Visceral Adipose Tissue During Obesity
    Zhou, Qiuzhong
    Fu, Zhenzhen
    Gong, Yingyun
    Seshachalam, Veerabrahma Pratap
    Li, Jia
    Ma, Yizhe
    Liang, Hui
    Guan, Wei
    Lin, Shibo
    Ghosh, Sujoy
    Sun, Lei
    Zhou, Hongwen
    OBESITY, 2020, 28 (11) : 2153 - 2162